Natural Course of Human T-Cell Leukemia Virus Type 1 Proviral DNA Levels in Carriers During Pregnancy
暂无分享,去创建一个
T. Tsukiyama | K. Yanagihara | D. Sasaki | H. Hasegawa | N. Fuchi | H. Masuzaki | K. Tsuruda | Kaori Ishihara | K. Miura | S. Miura
[1] S. Hanada,et al. Treatment and survival among 1594 patients with ATL. , 2015, Blood.
[2] S. Saito,et al. Standardization of Quantitative PCR for Human T-Cell Leukemia Virus Type 1 in Japan: a Collaborative Study , 2015, Journal of Clinical Microbiology.
[3] Steven Jacobson,et al. Digital droplet PCR (ddPCR) for the precise quantification of human T-lymphotropic virus 1 proviral loads in peripheral blood and cerebrospinal fluid of HAM/TSP patients and identification of viral mutations , 2014, Journal of NeuroVirology.
[4] Shunji Suzuki,et al. Current status of HTLV-1 carrier in Japanese pregnant women , 2014, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[5] S. Katamine,et al. Mother-to-child transmission of human T-cell lymphotropic virus type 1. , 2013, The Pediatric infectious disease journal.
[6] A. Saitoh,et al. Discrepancy between human T‐cell lymphotropic virus type I screening test and confirmatory tests in non‐endemic areas , 2012, The journal of obstetrics and gynaecology research.
[7] M. Matsuoka,et al. HTLV-1 modulates the frequency and phenotype of FoxP3+CD4+ T cells in virus-infected individuals , 2012, Retrovirology.
[8] S. Coughlan,et al. Multiplex real-time PCR for the detection and quantitation of HTLV-1 and HTLV-2 proviral load: addressing the issue of indeterminate HTLV results. , 2011, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[9] M. Satake,et al. Intra‐ and inter‐laboratory variability in human T‐cell leukemia virus type‐1 proviral load quantification using real‐time polymerase chain reaction assays: A multi‐center study , 2010, Cancer science.
[10] K. Yamaguchi,et al. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. , 2010, Blood.
[11] M. Sayegh,et al. Maternal Acceptance of the Fetus: True Human Tolerance , 2007, The Journal of Immunology.
[12] Elizabeth M. Maloney,et al. Natural history of viral markers in children infected with human T lymphotropic virus type I in Jamaica. , 2006, The Journal of infectious diseases.
[13] T. Gingeras,et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells , 2006, The Journal of experimental medicine.
[14] R. Wilks,et al. Human T lymphotropic virus types I and II western blot seroindeterminate status and its association with exposure to prototype HTLV-I. , 2006, The Journal of infectious diseases.
[15] M. Tomonaga,et al. Possible origin of adult T‐cell leukemia/lymphoma cells from human T lymphotropic virus type‐1‐infected regulatory T cells , 2005, Cancer science.
[16] A. G. Betz,et al. Regulatory T cells mediate maternal tolerance to the fetus , 2004, Nature Immunology.
[17] M. Matsuoka,et al. Genetic evidence of transmission of human T cell lymphotropic virus type 1 between spouses. , 2002, The Journal of infectious diseases.
[18] M. Matsuoka,et al. Sequential change of virus markers in seroconverters with community-acquired infection of human T lymphotropic virus type I. , 2001, The Journal of infectious diseases.
[19] W. Blattner,et al. Quantitative proviral DNA and antibody levels in the natural history of HTLV-I infection. , 1999, The Journal of infectious diseases.
[20] M. Matsuoka,et al. Rapid quantification of HTLV‐I provirus load: Detection of monoclonal proliferation of HTLV‐I‐infected cells among blood donors , 1999, International Journal of Cancer.
[21] M. Matsuoka,et al. Persistent clonal proliferation of human T-lymphotropic virus type I-infected cells in vivo. , 1997, Cancer research.
[22] S. Katamine,et al. Primary prevention of HTLV-1 in Japan. , 1997, Leukemia.
[23] J. Goedert,et al. Modelling the risk of adult T‐cell leukemia/lymphoma in persons infected with human T‐lymphotropic virus type I , 1989, International journal of cancer.